Satiety: Bigger Than Weight Management

Satiety, defined as the satisfied feeling of fullness following a meal,¹ has been a concept central to the weight management category because maintaining satiety means more time between meals, fewer cravings, and less snacking, leading to potential weight loss over time. This concept is even more relevant now that glucagon-like peptide 1 (GLP-1) receptor agonist drugs have become so popular. As Preeti Jethwa, PhD, scientific affairs manager, EMEA for Phynova, explains, “GLP-1 receptor agonists work by strengthening satiety pathways and moderating glucose, which reduces hunger and the persistent mental pull toward food.”²

What’s significant is the role satiety plays in moderating glucose, which helps shift the perspective on what promoting satiety means for one’s health and the nature of weight-management goals. Of course, the appeal of GLP-1s has been their weight-loss benefits, but as dietary ingredient manufacturers develop products that support satiety and even work through the GLP-1 pathway, there’s a bigger picture worth leveraging: metabolic health.

As Florencia Moreno Torres, MSc, global marketing manager for Rousselot, points out, metabolic health is defined by 5 markers, 1 of which is waist circumference, which affects or is affected by the other markers, including fasting glucose, triglycerides, cholesterol, and blood pressure.³

“The systems that regulate body weight are the same systems that regulate glucose handling, insulin signaling, satiety, hunger, energy use, muscle metabolism, and the microbiome,” adds Jethwa. “When these systems are working well, appetite settles, and weight becomes easier to maintain. When they are not, hunger intensifies, and weight becomes harder to regulate, not because of motivation, but because the body is physiologically signaling for more energy.”

Therefore, is it worth reframing weight management through the lens of metabolic health, effectively communicating the health benefits rather than the aesthetics? Citing a 2024 FMCG Gurus survey,⁴ Shil Kothari, president of Gateway Health Alliances, explains that 68% of consumers say they understand metabolic health, and “commonly associate poor metabolic health with weight gain, fatigue, diabetes, and heart disease.”

Kothari goes on to say that “Consumers are increasingly recognizing that long-term wellness is not just about losing weight, but about supporting overall metabolic health.”

However, there is room for more effective education and messaging, as the term remains somewhat abstract. “Brands will do well to focus on relatable benefits, such as healthy weight management, appetite control, satiety, and blood sugar balance, while connecting them to the broader concept of metabolic wellness,” says Kothari.

How Does Satiety Work in the Body?

It seems simple: You eat food, food fills your stomach, you feel full, and you stop eating. But why is it that this feeling of fullness can pass so quickly, and before you know it, you’re sticking your head into the fridge or pantry, planning your next move? Well, interestingly enough, Jethwa explains that satiety is fundamentally a hormonal event.

“The way glucose enters the bloodstream after eating directly shapes the release of gut-derived satiety hormones such as GLP-1 and peptide YY [PYY],” says Jethwa. “When glucose absorption is gradual, these hormones rise in a coordinated way to slow gastric emptying, support insulin efficiency, and signal the brain that energy needs are being met.^5,6 This creates a sustained satiety signal.”

“When these signaling pathways are functioning properly, people tend to feel fuller after meals and experience fewer cravings between meals, which leads to fewer calories consumed,” adds Kothari. “Blood sugar management is critical to this process because spikes and crashes in glucose levels can drive hunger, cravings, and overeating. More stable blood sugar levels help support sustained energy, fewer appetite fluctuations, and better control over eating and calorie intake.”

Jethwa points out that there is also a gut-brain and microbiome connection to satiety. Short-chain fatty acids (SCFAs) such as acetate, propionate, and butyrate, for example, can “stimulate additional GLP-1 and PYY release, prolonging the satiety signal and activating the gut-brain axis,” she explains. “This mechanism helps explain why slower digestion and more distal carbohydrate delivery support both appetite regulation and metabolic stability.”

When it comes to the microbiome, Jethwa explains that studies have shown that altering its composition through microbiome transfer has improved insulin sensitivity, and that alterations in the microbiome have also been found to influence the rate of weight regain after dieting.^7,8 “These pathways interact with satiety hormones and the gut–brain axis, shaping appetite in ways that extend beyond calorie intake alone,” says Jethwa.

Delivering Satiety Benefits Through Ingredient Innovation

Ingredient manufacturers are hard at work developing innovative products that address metabolic health. Many of these ingredients promote satiety, operating through various pathways. One example is an extract of mulberry leaves from Phynova, called Reducose, which works by slowing the “breakdown of carbohydrates in the upper small intestine, leading to a smaller early glucose rise and a gentler insulin response,” says Jethwa. “Human clinical trials consistently show lower postmeal glucose and insulin curves across all tested doses after real-world mixed meals.^9,10 This smoother pattern helps prevent the sharp postmeal dip that often leads to hunger and cravings.”

Nextida GC is a collagen peptide composition from Rousselot that, in animal research, has been shown to slow gastric emptying. “The longer the food stays in your stomach, the less hungry you feel,” says Torres. “Nextida GC delays gastric emptying significantly to the point where it helps you feel full for a longer period of time, reducing cravings and giving you that satiety feeling.”

Of course, this has broader health benefits as well, as research demonstrated that the collagen peptide also significantly lowered blood glucose response and increased plasma active GLP-1 in mice. Additionally, a human proof-of-concept study showed that the ingredient reduced postprandial glucose response at a 5-mg dose in healthy, normoglycemic, and prediabetic participants.¹¹

An oleoylethanolamide (OEA) ingredient from Saanroo, called Trpti, promotes satiety through a mechanism largely dependent on the vagus nerve, explains Ramasamy Venkatesh, managing director of Saanroo and Gencor Pacific. “OEA is a lipid mediator produced in the small intestine in response to food intake (specifically fat) that communicates with the brain to signal satiety, thereby reducing food intake,” says Venkatesh. More specifically, he explains that when food enters the small intestine, epithelial cells produce OEA, which then binds to peroxisome proliferator-activated receptor-alpha (PPAR-α), activating sensory nerve cells in the vagus nerve, connecting the gut to the brain.

“These sensory signals are transmitted to the nucleus tractus solitarius (NTS) in the brainstem, which is the primary relay site of the vagus nerve,” he says. “The signal travels further, leading to the activation of brain circuits that involve the release of oxytocin and histamine, ultimately reducing appetite.”^12,13

The OEA ingredient also enhances GLP-1 secretion by binding to GPR-119.

Finally, 2 botanical extracts from Gateway Health Alliance, Dyglomera (Dichrostachys glomerata) and CQR-300 (Cissus quadrangularis), were found to significantly inhibit DPP-4, enabling circulating endogenous GLP-1 to remain active for longer periods. This resulted in an approximately 300% increase in GLP-1 activity.¹⁴

“This sustained elevation in endogenous GLP-1 triggered a cascade of clinically meaningful effects, including significant increases in satiety scores, reductions in calorie intake, decreases in body weight, and body fat. Key metabolic biomarkers also improved, including fasting glucose, lipid parameters, and waist circumference,” explains Kothari.

Embracing the Bigger Picture

Satiety is a complex physiological process that extends beyond appetite reduction and weight management to confer important metabolic health benefits. “Reframing weight management through metabolic health is…both more accurate and more humane,” says Jethwa. “It shifts the narrative from ‘trying to eat less’ to supporting the body, so it does not feel compelled to eat more.”

References

1. Satiety-early. MedlinePlus. Accessed May 14, 2026. https://medlineplus.gov/ency/article/003127.htm 
2. van Can J, Sloth B, Jensen CB, Flint A, Blaak EE, Saris WH. Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults. Int J Obes (Lond). 2014;38(6):784-793. doi:10.1038/ijo.2013.162 
3. 5 markers for optimal metabolic health. Atlantic Health. January 10, 2025. Accessed May 14, 2026. https://www.atlantichealth.org/health-articles/healthy-living/5-signs-of-good-metabolic-health 
4. FMCG Gurus. Addressing metabolic health – awareness, insights and strategies – global report 2024. FMCG Gurus; 2024. Accessed May 14, 2026. https://fmcggurus.com/reports/fmcg-guras-addressing-metabolic-health-awareness-insights-and-strategies-global-report-2024/ 
5. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007;87(4):1409-1439. doi:10.1152/physrev.00034.2006 
6. Batterham RL, Cohen MA, Ellis SM, et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med. 2003;349(10):941-948. doi:10.1056/NEJMoa030204 
7. Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012;143(4):913-916.e7. doi:10.1053/j.gastro.2012.06.031 
8. Thaiss CA, Itav S, Rothschild D, et al. Persistent microbiome alterations modulate the rate of post-dieting weight regain. Nature. 2016;540(7634):544-551. doi:10.1038/nature20796 
9. Lown M, Fuller R, et al. Mulberry extract improves glucose tolerance and decreases insulin concentrations in normoglycaemic adults: results of a randomized double-blind placebo-controlled study. PLoS One. 2017;12(2):e0172239. doi:10.1371/journal.pone.0172239 
10. Thondre PS, Butler I, Tammam J, et al. Understanding the impact of different doses of Reducose® mulberry leaf extract on blood glucose and insulin responses after eating a complex meal: results from a double-blind, randomised, crossover trial. Nutrients. 2024;16(11):1670. doi:10.3390/nu16111670 
11. Grasset E, Briand F, Virgilio N, et al. A specific collagen hydrolysate improves postprandial glucose tolerance in normoglycemic and prediabetic mice and in a first proof of concept study in healthy, normoglycemic and prediabetic humans. Food Sci Nutr. 2024;12(11):9607-9620. doi:10.1002/fsn3.4538 
12. Provensi G, Coccurello R, Umehara H, et al. Satiety factor oleoylethanolamide recruits the brain histaminergic system to inhibit food intake. Proc Natl Acad Sci U S A. 2014;111(31):11527-11532. doi:10.1073/pnas.1322016111 
13. Hansen HS. Role of anorectic N-acylethanolamines in intestinal physiology and satiety control with respect to dietary fat. Pharmacol Res. 2014;86:18-25. doi:10.1016/j.phrs.2014.03.006 
14. Youovop J, Takuissu G, Minoue R, et al. Effects of Dichrostachys glomerata and Cissus quadrangularis extracts on GLP-1 secretion and DPP-4 activity in overweight and obese individuals: a randomized controlled trial. Medicina. 2026;62(1):41. doi:10.3390/medicina62010041